Roivant Sciences announced the launch of Respivant Sciences, a biopharmaceutical company focused on the lives of patients suffering from serious respiratory diseases...
PhaseBio is using its ELP platform to extend the half-life of proteins, peptides and other large molecules to create injectable drugs that can be administered less frequently.